Bringing Biologically Relevant Cells to Life - iPSC Technology in Discovery and Safety Assessment

Video   Dec 23, 2016

 

Type II diabetes and its associated co-morbidities are a growing global epidemic affecting an esimated 300 million patients worldwide. There currently is an abscence of therapeutic alternatives for halting or reversing disease progression. Furthermore, there is a lack of siutable human cellular models that recapitulate the biology of pancreatic beta-cells and which allow for drug screening activities at scale. AstraZeneca, in collaboration with the laboratory of Professor Douglas Melton (Harvard), are developing protocols to generate iPSC derived, functional, pancreatic beta-cells, at a scale comensurate with industry scale drug discovery. Data presented here demonstrates the succesful application of these protocols and shows the qualification of the generated cells in relation to their biological context. These cells are now being used in screening to generate novel chemical equity and identify new targets. In addition, data is presented that highlights the promise and power of combining precise genome editing (PGE) with iPSC technology to drive target validation, in a human context, with a precison and speed that has hitherto been unachievable. A specific case study is presented relating to Salt Inducible Kinase (SIK) target validation in chronic obstructive pulmonary disease. Here, PGE is applied to determine specific SIK isoform involvement in driving anti-inflamatory phenotypes in iPSC derived macrophages. This approach can be seen as a model for future combination of these two technologies in the target validation space.


 
 
 
 

Recommended Videos

The new Gibco™ One Shot™ FBS 50 mL bottle. Finally…Aliquot-free solution that reduces contamination.

Video

The Gibco One Shot FBS 50 mL bottle is designed to significantly improve your results and solve myriad challenges slowing down your research. Join the aliquot-free revolution today!

WATCH NOW

The First IVF Baby

Video

The development of in vitro fertilisation, or IVF, culminating in the ‘miraculous’ birth of Louise Joy Brown on 25 July 1978, was a defining moment for reproductive technology pioneered by British researchers.

WATCH NOW

CellStream™ Benchtop Flow Cytometer for Sensitive Cell Analysis

Video

The new CellStream™ benchtop flow cytometer delivers unparalleled sensitivity and flexibility for cell and particle analysis.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy